openPR Logo
Press release

Anterior Cruciate Ligament Injuries Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Mesoblast, Ltd., Omeros Corporation

04-28-2025 09:09 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Anterior Cruciate Ligament Injuries Market Statistics

DelveInsight's "Anterior Cruciate Ligament Injuries Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Anterior Cruciate Ligament Injuries, historical and forecasted epidemiology as well as the Anterior Cruciate Ligament Injuries market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The latest healthcare forecast report provides an in-depth analysis of Anterior Cruciate Ligament Injuries, offering comprehensive insights into the Anterior Cruciate Ligament Injuries revenue trends, prevalence, and treatment landscape. The report delves into key Anterior Cruciate Ligament Injuries statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Anterior Cruciate Ligament Injuries therapies. Additionally, we cover the landscape of Anterior Cruciate Ligament Injuries clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Anterior Cruciate Ligament Injuries treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Anterior Cruciate Ligament Injuries space.

To Know in detail about the Anterior Cruciate Ligament Injuries market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Anterior Cruciate Ligament Injuries Market Forecast
https://www.delveinsight.com/sample-request/anterior-cruciate-ligament-injuries-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Anterior Cruciate Ligament Injuries Market Report:
• The Anterior Cruciate Ligament Injuries market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Key Anterior Cruciate Ligament Injuries Companies: Mesoblast, Ltd., Omeros Corporation, and others
• Key Anterior Cruciate Ligament Injuries Therapies: MSB-CAR001 Combined With Hyaluronan, OMS103HP, and others
• The Anterior Cruciate Ligament Injuries market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Anterior Cruciate Ligament Injuries pipeline products will significantly revolutionize the Anterior Cruciate Ligament Injuries market dynamics.
• Around 200,000-250,000 ACL injuries occur annually in the United States alone.
• Females are 2-8 times more likely to suffer ACL injuries than males in similar sports.
• Most common among individuals aged 15 to 25 years, particularly athletes.
• High-risk sports include soccer, basketball, football, skiing, and gymnastics.
• Approximately 70% of ACL injuries occur through non-contact mechanisms (e.g., sudden pivoting or landing).
• Patients with one ACL injury have a higher risk of injuring the opposite knee

Anterior Cruciate Ligament Injuries Overview
Anterior Cruciate Ligament (ACL) Injuries refer to tears or sprains of the ACL, one of the major ligaments in the knee that helps stabilize the joint. These injuries often occur during sports activities involving sudden stops, jumps, or changes in direction, such as soccer, basketball, or skiing. Symptoms typically include a popping sound, severe knee pain, swelling, and instability. Treatment may involve rest, physical therapy, or surgical reconstruction depending on the severity.

Get a Free sample for the Anterior Cruciate Ligament Injuries Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Anterior Cruciate Ligament Injuries Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Anterior Cruciate Ligament Injuries Epidemiology Segmentation:
The Anterior Cruciate Ligament Injuries market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Anterior Cruciate Ligament Injuries
• Prevalent Cases of Anterior Cruciate Ligament Injuries by severity
• Gender-specific Prevalence of Anterior Cruciate Ligament Injuries
• Diagnosed Cases of Episodic and Chronic Anterior Cruciate Ligament Injuries

Download the report to understand which factors are driving Anterior Cruciate Ligament Injuries epidemiology trends @ Anterior Cruciate Ligament Injuries Epidemiology Forecast
https://www.delveinsight.com/sample-request/anterior-cruciate-ligament-injuries-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Anterior Cruciate Ligament Injuries Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Anterior Cruciate Ligament Injuries market or expected to get launched during the study period. The analysis covers Anterior Cruciate Ligament Injuries market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Anterior Cruciate Ligament Injuries Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Anterior Cruciate Ligament Injuries Therapies and Key Companies
• MSB-CAR001 Combined With Hyaluronan: Mesoblast, Ltd.
• OMS103HP: Omeros Corporation

Discover more about therapies set to grab major Anterior Cruciate Ligament Injuries market share @ Anterior Cruciate Ligament Injuries Treatment Landscape
https://www.delveinsight.com/sample-request/anterior-cruciate-ligament-injuries-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Anterior Cruciate Ligament Injuries Market Drivers
• Rising participation in high-impact sports and athletic activities
• Growing awareness about early diagnosis and treatment options
• Advancements in surgical techniques such as minimally invasive ACL reconstruction
• Increasing use of biologics (like PRP and stem cell therapies) to enhance healing
• Technological innovations in orthopedic implants and surgical devices
• High incidence of sports injuries among young adults and adolescents

Anterior Cruciate Ligament Injuries Market Barriers
• High cost of surgical procedures and postoperative care
• Risk of surgical complications and reinjury after ACL repair
• Limited access to advanced treatments in low- and middle-income regions
• Prolonged recovery time affecting patient willingness for surgery
• Variability in treatment outcomes, especially among older patients

Scope of the Anterior Cruciate Ligament Injuries Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Anterior Cruciate Ligament Injuries Companies: Mesoblast, Ltd., Omeros Corporation, and others
• Key Anterior Cruciate Ligament Injuries Therapies: MSB-CAR001 Combined With Hyaluronan, OMS103HP, and others
• Anterior Cruciate Ligament Injuries Therapeutic Assessment: Anterior Cruciate Ligament Injuries current marketed and Anterior Cruciate Ligament Injuries emerging therapies
• Anterior Cruciate Ligament Injuries Market Dynamics: Anterior Cruciate Ligament Injuries market drivers and Anterior Cruciate Ligament Injuries market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Anterior Cruciate Ligament Injuries Unmet Needs, KOL's views, Analyst's views, Anterior Cruciate Ligament Injuries Market Access and Reimbursement

To know more about Anterior Cruciate Ligament Injuries companies working in the treatment market, visit @ Anterior Cruciate Ligament Injuries Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/anterior-cruciate-ligament-injuries-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Anterior Cruciate Ligament Injuries Market Report Introduction
2. Executive Summary for Anterior Cruciate Ligament Injuries
3. SWOT analysis of Anterior Cruciate Ligament Injuries
4. Anterior Cruciate Ligament Injuries Patient Share (%) Overview at a Glance
5. Anterior Cruciate Ligament Injuries Market Overview at a Glance
6. Anterior Cruciate Ligament Injuries Disease Background and Overview
7. Anterior Cruciate Ligament Injuries Epidemiology and Patient Population
8. Country-Specific Patient Population of Anterior Cruciate Ligament Injuries
9. Anterior Cruciate Ligament Injuries Current Treatment and Medical Practices
10. Anterior Cruciate Ligament Injuries Unmet Needs
11. Anterior Cruciate Ligament Injuries Emerging Therapies
12. Anterior Cruciate Ligament Injuries Market Outlook
13. Country-Wise Anterior Cruciate Ligament Injuries Market Analysis (2019-2032)
14. Anterior Cruciate Ligament Injuries Market Access and Reimbursement of Therapies
15. Anterior Cruciate Ligament Injuries Market Drivers
16. Anterior Cruciate Ligament Injuries Market Barriers
17. Anterior Cruciate Ligament Injuries Appendix
18. Anterior Cruciate Ligament Injuries Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Latest Reports by DelveInsight:
• Erectile Dysfunction Market: https://www.delveinsight.com/report-store/erectile-dysfunction-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market
• Arteriovenous Malformations Market: https://www.delveinsight.com/report-store/vascular-malformations-market
• Mammography Devices Market: https://www.delveinsight.com/report-store/mammography-devices-market
• Global Kinase Inhibitor Market: https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market-insight
• Nerve Repair And Regeneration Devices- Market Insights: https://www.delveinsight.com/report-store/nerve-repair-and-regeneration-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anterior Cruciate Ligament Injuries Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Mesoblast, Ltd., Omeros Corporation here

News-ID: 3991368 • Views:

More Releases from DelveInsight Business Research

Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 12.80% by 2032, Evaluates DelveInsight
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates DelveInsight
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million by 2032 at a CAGR of 6.91% by 2032, Evaluates DelveInsight
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth. DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices

All 5 Releases


More Releases for Anterior

Anterior Uveitis Treatment Market Size Report 2032 | DelveInsight
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To know in detail about the Anterior Uveitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Anterior Uveitis Market Forecast-- https://www.delveinsight.com/sample-request/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Some of the
Anterior Uveitis Treatment Market Is Booming Worldwide | Soliris, Pfizer, AbbVie
The "Anterior Uveitis Treatment Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Anterior Uveitis Treatment Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the
Anterior Uveitis Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Anterior uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Anterior uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The Anterior Uveitis market report provides current treatment practices, emerging drugs, the market share of individual therapies, and the current and forecasted Anterior Uveitis market size
Global Anterior Uveitis Treatment Market - Forecast to 2026
The findings reviewed by GME stated that the Global Anterior Uveitis Treatment Market will expand with a CAGR value of 5.4 percent from 2021 to 2026. The demand for anterior uveitis treatment is expected to rise over the projected period, due to the increasing prevalence of anterior uveitis, the growing geriatric population, greater investment in the production of novel biologics, and additional funding from private companies. Furthermore, advances in molecular
Only a swab from the anterior nasal passage is required
Coronavirus rapid tests from nal von minden GmbH (Germany), already well-reviewed and widely used, have undergone another stage of development. A swab taken from the anterior nasal passage is now all that is needed to carry out a test, rather than from the posterior nasal passage or oropharynx as was previously necessary. The NADAL® COVID-19 Ag Test is available all over Europe from the 22nd February. “It’s much more comfortable when
Anterior Uveitis - Know Factors Driving the Market to Record Growth
A New Syndicate Global Anterior Uveitis Market Study is added in HTF MI database compiled covering key business segments and wider geographical scope to get deep dive analysed market data. The study brings a perfect bridging between qualitative and statistical data of Anterior Uveitis market. The study provides historical data (i.e. Consumption** & Value) from 2014 to 2018 and forecasted till 2026*. Some are the key & emerging players that